Rising six stories above Kendall Square, 325 Binney Street is the latest addition to the ‘most innovative square mile on ...

Moderna Faces Serious Misconduct Charges** A shocking report reveals that Moderna, a major player in the COVID-19 vaccine market, is facing suspens ...

In this phase 1 randomized controlled trial, urticaria was reported in several participants who received a messenger RNA ...

Bank of America Art Conservation Project grantees also include the Rothko Chapel in Houston and Sainte Chapelle in Paris.

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

The US Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine.

Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine.

Wall Street analysts expect Moderna (MRNA) to post quarterly loss of $2.92 per share in its upcoming report, which indicates a year-over-year increase of 4.9%. Revenues are expected to be $126.98 ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...